LBA55 Trastuzumab deruxtecan (T-DXd) in patients (Pts) with HER2-mutant metastatic non-small cell lung cancer (NSCLC): Interim results from the phase 2 DESTINY-Lung02 trial

Keiko Goto, K. Sang-We, Takafumi Kubo, Y. Goto, M-J. Ahn, David Planchard, Dongwook Kim, J.C-H. Yang, T-Y. Yang, Kaline Pereira, Kapil Saxena, Ryota Shiga, Yun Cheng, Mehreteab Aregay, Pasi A. Jänne